rs1553404358
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378454.1(ALMS1):c.6898delG(p.Val2300TrpfsTer43) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,461,428 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378454.1 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461428Hom.: 0 Cov.: 34 AF XY: 0.0000220 AC XY: 16AN XY: 726944
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:3
- -
- -
This sequence change creates a premature translational stop signal (p.Val2301Trpfs*43) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with ALMS1-related conditions (PMID: 28432734). ClinVar contains an entry for this variant (Variation ID: 553908). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.6901delG pathogenic mutation, located in coding exon 8 of the ALMS1 gene, results from a deletion of one nucleotide at nucleotide position 6901, causing a translational frameshift with a predicted alternate stop codon (p.V2301Wfs*43). This alteration has been reported as a compound heterozygote in a subject with features of Alstrom syndrome (Astuti D et al. Hum Mutat, 2017 Jul;38:764-777). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at